Reply to “Key Points to Consider When Evaluating Andexxa for Formulary Addition”
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1556-0961
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Reply to “Key Points to Consider When Evaluating Andexxa for Formulary Addition” ; volume:33 ; number:1 ; day:22 ; month:6 ; year:2020 ; pages:323-326 ; date:8.2020
Neurocritical care ; 33, Heft 1 (22.6.2020), 323-326, 8.2020
- Urheber
-
Mahan, Charles E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12028-020-01008-z
- URN
-
urn:nbn:de:101:1-2020092623515015863523
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 09:03 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mahan, Charles E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Sex, gender, and health biotechnology: points to consider
DNA Testing for Family Reunification in Canada: Points to Consider
DNA Testing for Family Reunification in Canada: Points to Consider
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Points-to-consider on the return of results in epigenetic research
Patient-Reported Outcomes (PROs) in HIV Infection: Points to Consider and Challenges
Properties, Collections, and the Successive Addition Argument: A Reply to Malpass
Reply to Letter to the Editor, Reply to Yasri & Wiwanitkit
Points to consider: efficacy and safety evaluations in the clinical development of ultra-orphan drugs
Reply to Ortner
Reply to Commentators
Reply to Arneson
Sex, gender, and health biotechnology: points to consider
DNA Testing for Family Reunification in Canada: Points to Consider
DNA Testing for Family Reunification in Canada: Points to Consider
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Points-to-consider on the return of results in epigenetic research
Patient-Reported Outcomes (PROs) in HIV Infection: Points to Consider and Challenges
Properties, Collections, and the Successive Addition Argument: A Reply to Malpass
Reply to Letter to the Editor, Reply to Yasri & Wiwanitkit
Points to consider: efficacy and safety evaluations in the clinical development of ultra-orphan drugs
Reply to Ortner
Reply to Commentators
Reply to Arneson
Sex, gender, and health biotechnology: points to consider
DNA Testing for Family Reunification in Canada: Points to Consider
DNA Testing for Family Reunification in Canada: Points to Consider
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Points-to-consider on the return of results in epigenetic research
Patient-Reported Outcomes (PROs) in HIV Infection: Points to Consider and Challenges
Properties, Collections, and the Successive Addition Argument: A Reply to Malpass
Reply to Letter to the Editor, Reply to Yasri & Wiwanitkit
Points to consider: efficacy and safety evaluations in the clinical development of ultra-orphan drugs
Reply to Ortner
Reply to Commentators